The secretary of Health and Human Services overruled Wednesday a Food & Drug Administration recommendation that would have made the emergency contraceptive pill Plan B One-Step available over the counter to girls younger than 17. In February of this past year, Teva Woman’s Health Inc, the drug maker, had asked the FDA to make the drug available without prescription to all sexually active girls and women. The FDA found the pill to be “safe and effective,” but HHS secretary, Kathleen Sebelius, says more data is needed. The president of the American Society for Reproductive Medicine, Dolores J. Lamb, says that data in fact clears that the emergency contraception can be used safely by adolescent women without requiring a prescription. “Sadly, it appears that once again our leaders are putting political expediency ahead of reproductive health,” says Lamb. Until things change, it has been suggested that the FDA consider allowing over-the-counter access for girls under the age of 17 if they are accompanied by a parent to the drugstore.